• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度的结核病流行病学:综述

Tuberculosis epidemiology in India: a review.

作者信息

Chadha V K

机构信息

National Tuberculosis Institute, Bangalore, India.

出版信息

Int J Tuberc Lung Dis. 2005 Oct;9(10):1072-82.

PMID:16229217
Abstract

High prevalence and incidence of disease and a high rate of transmission of infection characterise the tuberculosis (TB) situation in India. Disease surveys conducted in different parts of the country since the 1950s have reported prevalences of smear-positive pulmonary TB (PTB) of 0.6-7.6 per 1000 population, culture-positive TB of 1.7-9.8 and culture and/or smear-positive TB of 1.8-12.7. The incidence of smear-positive PTB has been observed in the range of 1.0-1.6/1000 and that of culture-positive PTB 1.0-2.5/1000 in the limited number of studies carried out. The annual risk of tuberculous infection (ARTI) had been estimated at 1-2% for most of the tuberculin surveys carried out in different areas over different time periods. During a nationwide study in 2000-2003, the average ARTI in the country was estimated at 1.5%. An increasing trend has been observed in human immunodeficiency virus (HIV) seropositivity among TB cases, which has been found to vary between 0.4% and 28.8% in different studies conducted mostly at tertiary health care centres. The proportion of new cases with multidrug resistance (MDR) was relatively low, at 0.5-5.3%. However, the proportion of MDR cases among previously treated cases varied between 8% and 67%.

摘要

疾病的高患病率和发病率以及高感染传播率是印度结核病情况的特征。自20世纪50年代以来在该国不同地区进行的疾病调查显示,涂片阳性肺结核(PTB)的患病率为每1000人口0.6 - 7.6例,培养阳性结核病为1.7 - 9.8例,培养和/或涂片阳性结核病为1.8 - 12.7例。在已开展的有限数量研究中,涂片阳性PTB的发病率在1.0 - 1.6/1000范围内,培养阳性PTB的发病率在1.0 - 2.5/1000范围内。在不同时期不同地区进行的大多数结核菌素调查中,结核感染的年风险(ARTI)估计为1 - 2%。在2000 - 2003年的一项全国性研究中,该国的平均ARTI估计为1.5%。在结核病病例中观察到人类免疫缺陷病毒(HIV)血清阳性率呈上升趋势,在主要在三级医疗中心进行的不同研究中,该率在0.4%至28.8%之间变化。新的耐多药(MDR)病例比例相对较低,为0.5 - 5.3%。然而,既往治疗病例中的MDR病例比例在8%至67%之间变化。

相似文献

1
Tuberculosis epidemiology in India: a review.印度的结核病流行病学:综述
Int J Tuberc Lung Dis. 2005 Oct;9(10):1072-82.
2
[Tuberculosis prevalence survey in Japan].[日本结核病患病率调查]
Kekkaku. 2009 Nov;84(11):713-20.
3
Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.印度古吉拉特邦耐药结核病监测
Int J Tuberc Lung Dis. 2009 Sep;13(9):1154-60.
4
Relationship of ARTI to incidence and prevalence of tuberculosis in a district of south India.印度南部某地区急性呼吸道感染(ARTI)与结核病发病率及患病率的关系。
Int J Tuberc Lung Dis. 2006 Jan;10(1):115-7.
5
HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.耐多药和广泛耐药结核病患者中的艾滋病毒合并感染——一种趋势。
J Indian Med Assoc. 2009 May;107(5):281-2, 284-6.
6
The impact of the HIV epidemic on tuberculosis transmission in Tanzania.艾滋病毒流行对坦桑尼亚结核病传播的影响。
AIDS. 2006 Apr 4;20(6):915-21. doi: 10.1097/01.aids.0000218557.44284.83.
7
The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.结核病负担日益加重:全球趋势及与艾滋病流行的相互影响
Arch Intern Med. 2003 May 12;163(9):1009-21. doi: 10.1001/archinte.163.9.1009.
8
Multidrug-resistant tuberculosis in a low-incidence region shows a high rate of transmission.低发病率地区的耐多药结核病呈现出高传播率。
Int J Tuberc Lung Dis. 2007 Apr;11(4):429-35.
9
Childhood human immunodeficiency virus and tuberculosis co-infections: reconciling conflicting data.儿童人类免疫缺陷病毒与结核病合并感染:协调相互矛盾的数据。
Int J Tuberc Lung Dis. 1998 Oct;2(10):844-51.
10
Transmission of tuberculosis in an endemic urban setting in Brazil.巴西地方性流行城市环境中结核病的传播
Int J Tuberc Lung Dis. 2000 Jan;4(1):18-25.

引用本文的文献

1
A Rare Case of Shoulder Tuberculosis Managed with Anti-tuberculosis Treatment and Antibiotic Coated Cement Spacer.1例采用抗结核治疗及抗生素涂层骨水泥间隔器治疗的肩部结核罕见病例
J Orthop Case Rep. 2025 May;15(5):29-32. doi: 10.13107/jocr.2025.v15.i05.5544.
2
Mathematical modelling and analysis of COVID-19 and tuberculosis transmission dynamics.新型冠状病毒肺炎与结核病传播动力学的数学建模及分析
Inform Med Unlocked. 2023;38:101235. doi: 10.1016/j.imu.2023.101235. Epub 2023 Mar 31.
3
Screening of Latent Tuberculous Infection (LTBI) before Starting Anti-Tumor Necrosis Factor Therapy in Patients with Psoriasis: A Primer for Clinical Dermatologist.
银屑病患者开始抗肿瘤坏死因子治疗前潜伏结核感染(LTBI)的筛查:临床皮肤科医生入门指南
Indian J Dermatol. 2021 Sep-Oct;66(5):501-507. doi: 10.4103/ijd.IJD_649_16.
4
Active Case Finding for Tuberculosis in India: A Syntheses of Activities and Outcomes Reported by the National Tuberculosis Elimination Programme.印度结核病主动病例发现:国家结核病消除计划报告的活动与成果综述
Trop Med Infect Dis. 2021 Nov 30;6(4):206. doi: 10.3390/tropicalmed6040206.
5
Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in India.在印度,应考虑对所有肺结核患者的家庭接触者进行结核病预防性治疗。
PLoS One. 2020 Jul 29;15(7):e0236743. doi: 10.1371/journal.pone.0236743. eCollection 2020.
6
COVID-19 and tuberculosis: A mathematical model based forecasting in Delhi, India.新型冠状病毒肺炎与结核病:基于数学模型对印度德里的预测
Indian J Tuberc. 2020 Apr;67(2):177-181. doi: 10.1016/j.ijtb.2020.05.006. Epub 2020 May 12.
7
Prevalence of pulmonary tuberculosis in India: A systematic review and meta-analysis.印度肺结核的患病率:一项系统评价与荟萃分析
Lung India. 2020 Jan-Feb;37(1):45-52. doi: 10.4103/lungindia.lungindia_181_19.
8
Sub-national TB prevalence surveys in India, 2006-2012: Results of uniformly conducted data analysis.印度 2006-2012 年的国家以下层面结核流行情况调查:统一开展数据分析的结果。
PLoS One. 2019 Feb 22;14(2):e0212264. doi: 10.1371/journal.pone.0212264. eCollection 2019.
9
Tuberculosis preventive treatment: the next chapter of tuberculosis elimination in India.结核病预防性治疗:印度结核病消除的新篇章。
BMJ Glob Health. 2018 Oct 8;3(5):e001135. doi: 10.1136/bmjgh-2018-001135. eCollection 2018.
10
Infectious uveitis: an Asian perspective.感染性葡萄膜炎:亚洲视角。
Eye (Lond). 2019 Jan;33(1):50-65. doi: 10.1038/s41433-018-0224-y. Epub 2018 Oct 12.